Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Bone metastases and breast cancer.

× No keyword cloud information.

19 in total

1. Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain.

Authors: M J Schwei; P Honore; S D Rogers; J L Salak-Johnson; M P Finke; M L Ramnaraine; D R Clohisy; P W Mantyh
Journal: J Neurosci Date: 1999-12-15 Impact factor: 6.167

Review 2. Bisphosphonates and other bone agents for breast cancer.

Authors: Brent O'Carrigan; Matthew Hf Wong; Melina L Willson; Martin R Stockler; Nick Pavlakis; Annabel Goodwin
Journal: Cochrane Database Syst Rev Date: 2017-10-30

Review 3. Antitumour effects of bisphosphonates: first evidence and possible mechanisms.

Authors: I J Diel
Journal: Drugs Date: 2000-03 Impact factor: 9.546

4. The flare phenomenon: far from fair and square.

Authors: W D van Schelven; E K Pauwels
Journal: Eur J Nucl Med Date: 1994-05

Review 5. Clodronate: a review of its use in breast cancer.

Authors: M Hurst; S Noble
Journal: Drugs Aging Date: 1999-08 Impact factor: 3.923

6. Parathyroid hormone-related protein: primary osteolytic factor produced by breast tumor cells in vitro?

Authors: A Tabuenca; S Mohan; C A Garberoglio; P I Borgen; T Rosol; T A Linkhart
Journal: World J Surg Date: 1995 Mar-Apr Impact factor: 3.352

7. Behavioral, medical imaging and histopathological features of a new rat model of bone cancer pain.

Authors: Louis Doré-Savard; Valérie Otis; Karine Belleville; Myriam Lemire; Mélanie Archambault; Luc Tremblay; Jean-François Beaudoin; Nicolas Beaudet; Roger Lecomte; Martin Lepage; Louis Gendron; Philippe Sarret
Journal: PLoS One Date: 2010-10-29 Impact factor: 3.240

8. Hypercalcemia in patients with breast cancer: a survival study.

Authors: S de Wit; F J Cleton
Journal: J Cancer Res Clin Oncol Date: 1994 Impact factor: 4.553

9. The salubrious effect of tamoxifen [correction of Tamaxifen] on serum marker enzymes, glycoproteins, and lysosomal enzymes level in breast cancer woman.

Authors: M Thangaraju; J Rameshbabu; H Vasavi; S Ilanchezhian; R Vinitha; P Sachdanandam
Journal: Mol Cell Biochem Date: 1998-08 Impact factor: 3.396

10. Use of intravenous bisphosphonates in older women with breast cancer.

Authors: Sharon H Giordano; Shenying Fang; Zhigang Duan; Yong-Fang Kuo; Gabriel N Hortobagyi; James S Goodwin
Journal: Oncologist Date: 2008-05